---
figid: PMC4373477__jcmm0014-2570-f1
figtitle: Simplified diagram of the Ras/ERK pathway and SST effects through PTPs,
  SHP-1 and SHP-2
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Phytomonas oxycareni
organisms_ner:
- Mus musculus
- Bos taurus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
pmcid: PMC4373477
filename: jcmm0014-2570-f1.jpg
figlink: /pmc/articles/PMC4373477/figure/fig01/
number: F1
caption: 'A simplified diagram of the Ras/ERK pathway and SST effects through PTPs,
  SHP-1 and SHP-2. Yellow lines show activation, red lines show inhibition of the
  corresponding protein. Note SHP-1 and SHP-2 inhibition of growth factor receptors,
  SHP-1 inhibition of ERK 1/2, SHP-2 inhibition of Raf kinase shown in blue lines.
  Src and SHP-2 activates SHP-1. As a result, SHP-1 and SHP-2 lead the cells to accumulate
  in G1 phase and inhibit entry in the S phase of the cell cycle. For simplicity the
  SSTR subtype-specific effects has not been shown separately. Abbreviations: ATF1,
  activating transcription factor; CcnD1, cyclin D1; CREB, cAMP responsive element
  binding protein; ERK, extracellular signal-regulated protein kinase; GAP, GTPase-activating
  protein; GEF, guanine nucleotide exchange factor; GRB2, growth factor receptor binding
  protein 2; KSR, kinase suppressor of Ras; mTOR, mammalian Target of Rapamycin; MEK,
  mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase; MSK,
  mitogen and stress activated kinase; NF-κB, nuclear factor-κB; p90RSK, p90 ribosomal
  S6 kinase; RTK, receptor tyrosine kinase; Src, cytosolic tyrosine kinase; SHP-1,
  SH-2 domain containing cytosolic tyrosine phosphatase 1; SHP-2, SH-2 domain containing
  cytosolic tyrosine phosphatase 2; SOS, mammalian son-of-sevenless; SST, somatostatin;
  SSTR, somatostatin receptor.'
papertitle: 'Somatostatin receptor biology in neuroendocrine and pituitary tumours:
  part 1 – molecular pathways.'
reftext: Mehtap Cakir, et al. J Cell Mol Med. 2010 Nov;14(11):2570-2584.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9641157
figid_alias: PMC4373477__F1
figtype: Figure
redirect_from: /figures/PMC4373477__F1
ndex: e7c48e6b-ded5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4373477__jcmm0014-2570-f1.html
  '@type': Dataset
  description: 'A simplified diagram of the Ras/ERK pathway and SST effects through
    PTPs, SHP-1 and SHP-2. Yellow lines show activation, red lines show inhibition
    of the corresponding protein. Note SHP-1 and SHP-2 inhibition of growth factor
    receptors, SHP-1 inhibition of ERK 1/2, SHP-2 inhibition of Raf kinase shown in
    blue lines. Src and SHP-2 activates SHP-1. As a result, SHP-1 and SHP-2 lead the
    cells to accumulate in G1 phase and inhibit entry in the S phase of the cell cycle.
    For simplicity the SSTR subtype-specific effects has not been shown separately.
    Abbreviations: ATF1, activating transcription factor; CcnD1, cyclin D1; CREB,
    cAMP responsive element binding protein; ERK, extracellular signal-regulated protein
    kinase; GAP, GTPase-activating protein; GEF, guanine nucleotide exchange factor;
    GRB2, growth factor receptor binding protein 2; KSR, kinase suppressor of Ras;
    mTOR, mammalian Target of Rapamycin; MEK, mitogen-activated protein/extracellular
    signal-regulated kinase (ERK) kinase; MSK, mitogen and stress activated kinase;
    NF-κB, nuclear factor-κB; p90RSK, p90 ribosomal S6 kinase; RTK, receptor tyrosine
    kinase; Src, cytosolic tyrosine kinase; SHP-1, SH-2 domain containing cytosolic
    tyrosine phosphatase 1; SHP-2, SH-2 domain containing cytosolic tyrosine phosphatase
    2; SOS, mammalian son-of-sevenless; SST, somatostatin; SSTR, somatostatin receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Sst
  - Lmx1a
  - ras
  - Hras
  - Kras
  - Rem1
  - Grb2
  - Zhx2
  - Gart
  - Map2k1
  - Map2k2
  - Ptpn11
  - Ephb2
  - Mapk1
  - Ptpn6
  - Sirpa
  - Nr0b2
  - Tsc2
  - Tsc1
  - Src
  - Rps6ka1
  - Rps6ka2
  - Sik1
  - H3
  - Atf1
  - Fos
  - Jun
  - Ccnd1
  - Creb1
  - Nfkb1
  - Myc
  - Nol3
  - Elk1
  - Kcnh8
  - SST
  - GRB2
  - PTPN11
  - TSC2
  - TSC1
  - SRC
  - ATF1
  - FOS
  - JUN
  - CCND1
  - CREB1
  - MYC
  - ELK1
  - Pck1
  - Ephb1
  - H2bc1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - XYLT2
  - SOS1
  - SOS2
  - MTG1
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - PTPN6
  - CCL26
  - FGR
  - FYN
  - YES1
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - SIK1
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - GDNF
  - ETS1
  - ETS2
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF2
  - NFKB1
  - KCNH4
  - KCNH8
  - MAGE
  - Ras64B
  - Ras85D
  - drk
  - Raf
  - Sos
  - amon
  - Dsor1
  - csw
  - Erk7
  - rl
  - gig
  - Src42A
  - Csk
  - Src64B
  - msk
  - JIL-1
  - babo
  - kay
  - Jra
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - CrebB
  - CrebA
  - Dif
  - dl
  - Rel
  - LanB2
  - anon-70Db
  - sst2
  - rab1ab
  - grb2b
  - map2k1
  - map2k2a
  - ptpn11a
  - ptpn6
  - tsc2
  - tsc1b
  - src
  - atf1
  - fosab
  - jun
  - ccnd1
  - myca
  - elk1
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
